The effect of ABCA1 gene polymorphisms on ischaemic stroke risk and relationship with lipid profile.

Department of Medicine and Therapeutics, University of Aberdeen, UK.
BMC Medical Genetics (Impact Factor: 2.45). 02/2007; 8:30. DOI: 10.1186/1471-2350-8-30
Source: PubMed

ABSTRACT Ischaemic stroke is a common disorder with genetic and environmental components contributing to overall risk. Atherothromboembolic abnormalities, which play a crucial role in the pathogenesis of ischaemic stroke, are often the end result of dysregulation of lipid metabolism. The ATP Binding Cassette Transporter (ABCA1) is a key gene involved in lipid metabolism. It encodes the cholesterol regulatory efflux protein which mediates the transfer of cellular phospholipids and cholesterol to acceptor apolipoproteins such as apolipoprotein A-I (ApoA-I). Common polymorphisms in this gene affect High Density Lipoprotein Cholesterol (HDL-C) and Apolipoprotein A-I levels and so influence the risk of atherosclerosis. This study has assessed the distribution of ABCA1 polymorphisms and haplotype arrangements in patients with ischaemic stroke and compared them to an appropriate control group. It also examined the relationship of these polymorphisms with serum lipid profiles in cases and controls.
We studied four common polymorphisms in ABCA1 gene: G/A-L158L, G/A-R219K, G/A-G316G and G/A-R1587K in 400 Caucasian ischaemic stroke patients and 487 controls. Dynamic Allele Specific Hybridisation (DASH) was used as the genotyping assay.
Genotype and allele frequencies of all polymorphisms were similar in cases and controls, except for a modest difference in the ABCA1 R219K allele frequency (P-value = 0.05). Using the PHASE2 program, haplotype frequencies for the four loci (158, 219, 316, and 1587) were estimated in cases and controls. There was no significant difference in overall haplotypes arrangement in patients group compared to controls (p = 0.27). 2211 and 1211 haplotypes (1 = common allele, 2 = rare allele) were more frequent in cases (p = 0.05). Adjusted ORs indicated 40% and 46% excess risk of stroke for these haplotypes respectively. However, none of the adjusted ORs were statistically significant. Individuals who had R219K "22" genotype had a higher LDL level (p = 0.001).
Our study does not support a major role for the ABCA1 gene as a risk factor for ischaemic stroke. Some haplotypes may confer a minor amount of increased risk or protection. Polymorphisms in this gene may influence serum lipid profile.

  • [Show abstract] [Hide abstract]
    ABSTRACT: Background Epidemiological studies have shown a strong inverse relationship between HDL cholesterol (HDLc) levels and coronary artery disease (CAD), and low concentration of plasma HDLc is considered as an independent risk factor for premature atherosclerosis. Mutations inABCA1, CETP, and LCAT reduce HDLc in humans. Objective Up to date, no study had tested the association between these polymorphisms and PCAD in Egyptian population. Here we searched for ABCA1 (rs2230806), CETP (rs708272), and LCAT (rs5923) mutations in Egyptian population and investigate the possible association between these gene polymorphisms and premature coronary artery disease. We aimed to investigate the association between ABCA1, CETP, and LCAT genes polymorphisms and PCAD in Egyptians. Methods Two hundred and thirty-five Egyptian individuals116 individuals with documented premature CAD (PCAD group) and 119 control subjectswere enrolled in the study. Results: Mutation carriers with low HDLc had elevated risk of PCAD (odds ratio (OR) =11.38 for ABCA1mutation carriers, p=0.000; OR=5.41 for CETP mutation carriers, p=0.000; OR=5.92 for LCAT mutation carriers, p=0.000).Moreover, mutations in ABCA1, CETP, and LCAT significantly associated with hyperlipidemia in this study. Conclusion These observations show that R allele of ABCA1, B1 allele of CETP, and T allele LCAT genes are associated with PCAD in Egyptians. They have more considerable effect on patients with low HDLc.
    Journal of Clinical Lipidology 07/2014; · 3.59 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: Recently, many studies have been focused on the association between the ATP-binding cassette transporter A1 (ABCA1) gene R219K polymorphism and ischemic stroke (IS). However, the study results have been inconsistent, especially in the Chinese population. Therefore, we performed a meta-analysis to better clarify the association between the ABCA1 gene and IS. All of the relevant studies used in our meta-analysis were identified using PubMed, OVID, Cochrane Library, Chinese Wan Fang database, Chinese VIP database, China National Knowledge Infrastructure (CNKI), and China Biological Medicine Database (CBM) up to May 2013. Statistical analysis was conducted with STATA software version 11.0. Odds ratios with 95% confidence intervals were applied to evaluate the strength of the association between ABCA1 gene R219K polymorphism and IS. Heterogeneity was evaluated using the Q-test and I(2) statistic. The funnel plots, Begg's and Egger's regression tests were used to assess the publication bias. Our meta-analysis showed the dominant genetic model (OR=0.92, 95% CI: 0.88-0.96), the recessive genetic model (OR=0.73, 95% CI: 0.51-1.05), the homozygote genetic model (OR=0.64, 95% CI: 0.44-0.94), the heterozygote genetic model (OR=0.81, 95% CI: 0.69-0.95), and the allelic genetic model (OR=0.83, 95% CI: 0.69-0.99). For R219K in IS, there were significant associations with these genetic models, but not with the recessive genetic model. Our meta-analysis indicated that the ABCA1 gene R219K polymorphism might be associated with IS and the K allele might be a protective factor in the Chinese population.
    Journal of the neurological sciences 10/2013; · 2.32 Impact Factor
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Microparticles efflux is known to be mediated by ABCA1 protein and the plasma level of these cell derived microparticles is observed to be elevated considerably during human malaria infection. Therefore two polymorphisms at position -477 and -320 in the promoter of the ABCA1 gene were genotyped and tested for association with the plasma MP level in four groups of malaria patients segregated according to the clinical severity i.e. cerebral malaria (CM), multiorgan dysfunction (MOD), noncerebral severe malaria (NCSM) and uncomplicated malaria (UM). TruCount(™) tube based Flow cytometric method was used for the exact quantification of different cell derived MPs in patients. Polymorphisms in the ABCA1 gene promoter was analysed by means of polymerase chain reaction confronting two pair primer method followed by restriction fragment length polymorphism in 428 malaria patients. The level of circulating plasma MPs was significantly higher in febrile patients with P falciparum infection especially in CM patients compared to healthy individuals. The homozygous wild type -477 and -320 genotype was observed to be significantly higher in severe malaria patients. These patients also showed marked increase in the plasma MP number compared to UM patients. We report for the first time, an association of ABCA1 promoter polymorphisms with susceptibility to severe malaria, especially to CM and MOD, indicating the protective effect of the mutant variant of the polymorphism. We hypothesise that the -477T and -320G polymorphism affect the downregulation of MP efflux and may be a predictor of organ complication during falciparum malaria infection.
    Infection and immunity 02/2013; · 4.16 Impact Factor

Full-text (2 Sources)

Available from
Jun 5, 2014